Johannet P, Liu W, Fenyo D, Wind-Rotolo M, et al. Baseline Serum Autoantibody Signatures Predict Recurrence and Toxicity in Melanoma Patients Receiving Adjuvant Immune Checkpoint Blockade. Clin Cancer Res 2022;28:4121-4130.
PMID: 36106402